Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells (Q39464528)

12 September 2017

Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells (English)

1 reference

12 September 2017

1 reference

6

Len Neckers

1 reference

12 September 2017

Manabu Tatokoro

1

1 reference

12 September 2017

Fumitaka Koga

2

1 reference

12 September 2017

Soichiro Yoshida

3

1 reference

12 September 2017

Satoru Kawakami

4

1 reference

12 September 2017

Yasuhisa Fujii

5

1 reference

12 September 2017

Kazunori Kihara

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

10 November 2011

1 reference

International Journal of Cancer

12 September 2017

1 reference

12 September 2017

131

1 reference

12 September 2017

4

1 reference

12 September 2017

987-996

1 reference

12 September 2017

Cancer statistics, 2010

1 reference

Tumour stem cells and drug resistance

21 January 2018

1 reference

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

Cancer stem cells--old concepts, new insights.

21 January 2018

1 reference

Cancer stem cell: target for anti-cancer therapy

21 January 2018

1 reference

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

21 January 2018

1 reference

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

Identification of human brain tumour initiating cells

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

21 January 2018

1 reference

Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation

21 January 2018

1 reference

Heat shock protein 90 as a molecular target for cancer therapeutics

21 January 2018

1 reference

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

21 January 2018

1 reference

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

21 January 2018

1 reference

Establishment of cell strains from human urothelial carcinoma and their morphological characterization

21 January 2018

1 reference

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

Identification of gastric cancer stem cells using the cell surface marker CD44.

21 January 2018

1 reference

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

21 January 2018

1 reference

Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.

21 January 2018

1 reference

HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

21 January 2018

1 reference

Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells

21 January 2018

1 reference

Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models

21 January 2018

1 reference

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells

21 January 2018

1 reference

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice

21 January 2018

1 reference

Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome

21 January 2018

1 reference

Brain cancer stem cells display preferential sensitivity to Akt inhibition

21 January 2018

1 reference

Cisplatin abrogates the geldanamycin-induced heat shock response

21 January 2018

1 reference

HSP90 and the chaperoning of cancer

21 January 2018

1 reference

Heat-shock proteins as regulators of apoptosis

21 January 2018

1 reference

Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer

21 January 2018

1 reference

17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells

21 January 2018

1 reference

Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells

21 January 2018

1 reference

12 December 2020

STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer.

1 reference

12 December 2020

P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death

1 reference

12 December 2020

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

1 reference

12 December 2020

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

12 December 2020

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

12 December 2020

Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells

1 reference

12 December 2020

Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.

1 reference

12 December 2020

Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.

1 reference

12 December 2020

[Pharmacokinetics of cis-platinum diammine dichloride]

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.26475

1 reference

12 September 2017

1 reference